WI
ABBV icon

Westbourne Investments’s AbbVie ABBV Stock Holding History

Westbourne Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
5,955
+900
+18% +$194K 0.61% 47
2026
Q1 		$1.1M Sell
5,055
-100
-2% -$22.2K 0.52% 57
2025
Q4 		$1.18M Hold
5,155
– – 0.55% 53
2025
Q3 		$1.12M Sell
5,155
-105
-2% -$21.4K 0.54% 54
2025
Q2 		$976K Sell
5,260
-2,125
-29% -$395K 0.52% 53
2025
Q1 		$1.55M Buy
7,385
+100
+1% +$19.4K 0.93% 37
2024
Q4 		$1.29M Buy
+7,285
New +$1.34M 0.76% 39

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Westbourne Investments's ABBV Position: Q2 2026 in Review

Westbourne Investments increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $194K and bringing the position to 5,955 shares worth $1.5M. The position accounts for 0.61% of the portfolio, ranked #47.

Westbourne Investments first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.55M in Q1 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Westbourne Investments held 5,955 shares of AbbVie worth $1.5M as of Q2 2026.
  • Westbourne Investments bought 900 AbbVie shares in Q2 2026, an estimated $194K.
  • AbbVie made up 0.61% of Westbourne Investments's portfolio in Q2 2026, its #47 holding.
  • Westbourne Investments first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Westbourne Investments's AbbVie position peaked at $1.55M in Q1 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.